SCHEMBL24497194

SCHEMBL24497194

CNCCOCCOc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLH Q9Y253 8/20 0.72
▸ MEN1 O00255 4/20 0.64
▸ KMT2A Q03164 4/20 0.64
▸ KDM4E B2RXH2 4/20 0.64
▸ POLB P06746 3/20 0.64
▸ GAA P10253 3/20 0.64
▸ RECQL P46063 3/20 0.64
▸ HSD17B10 Q99714 3/20 0.64
▸ MMP1 P03956 2/20 0.64
▸ MAPT P10636 2/20 0.64
▸ APEX1 P27695 2/20 0.64
▸ BLM P54132 2/20 0.64
▸ HTT P42858 1/20 0.64
▸ SRC P12931 2/20 0.55
▸ NOX4 Q9NPH5 2/20 0.55
▸ EPHX2 P34913 2/20 0.55
▸ USP2 O75604 2/20 0.55
▸ TP53 P04637 2/20 0.55
▸ CYP1A2 P05177 2/20 0.55
▸ CYP3A4 P08684 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20630949 0.90 POLH (0.68) POLHMEN1KMT2AKDM4EPOLB
SCHEMBL20630933 0.88 POLH (0.89) POLHMEN1KMT2AKDM4EPOLB
SCHEMBL20630991 0.87 POLH (0.77) POLHMEN1KMT2AKDM4EPOLB
SCHEMBL20630770 0.87 POLH (0.67) POLHMEN1KMT2AKDM4EPOLB
SCHEMBL20631318 0.86 POLH (0.67) POLHMEN1KMT2AKDM4EPOLB
SCHEMBL20630799 0.86 POLH (0.66) POLHMEN1KMT2AKDM4EPOLB
SCHEMBL20630208 0.85 POLH (0.65) POLHMEN1KMT2AKDM4EPOLB
SCHEMBL20630753 0.85 POLH (0.64) POLHMEN1KMT2AKDM4EPOLB
SCHEMBL17620378 0.84 POLH (0.89) POLHMEN1KMT2AKDM4EPOLB
SCHEMBL10728956 0.84 POLH (1.00) POLHMEN1KMT2AKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022118186-A1 SENOTHERAPEUTIC COMPOUND BIONEXA S.R.L. (IT) 2022-06-09 — — WO disclosed
Send feedback